MedTrop 2019

Congress of the Brazilian Society of Tropical Medicine

28-31 July 2019
Belo Horizonte, Brazil

  • DNDi participating in several round tables on Chagas disease, leishmaniasis, and hepatitis C

R&D Portfolio Update February 2019: DNDi Hepatitis C programme

The first stage of the clinical trial in Malaysia and Thailand testing the ravidasvir/sofosbuvir combination showed excellent results in 301 chronically infected adults, as 97% of those enrolled were cured. Cure rates were notably high for the hardest-to-treat patients. Stage 2 of the study, to confirm the pangenotypic potential of the combination, has started.

4th National Hepatitis Conference 2019

7-8 March 2019
Kuala Lumpur, Malaysia

  • François Bompart, Director of Paediatric HIV/HCV Programmes – panel discussion on collaborative R&D model for hepatitis C
  • Isabelle Andrieux-Meyer, Head of Clinical Development Paediatric HIV/HCV Programmes – presentation of the HCV STORM Stage 1 results

Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission

by Cooke GS, Andrieux-Meyer I, Applegate TL, Atun R, Burry JR, Cheinquer H, Dusheiko G, Feld JJ, Gore C, Griswold MG, Hamid S, Hellard ME, Hou J, Howell J, Jia J, Kravchenko N, Lazarus JV, Lemoine M, Lesi OA, Maistat L, McMahon BJ, Razavi H, Roberts TR, Simmons B, Sonderup MW, Spearman CW, Taylor BE, Thomas DL, Waked I, Ward JW, Wiktor SZ, on behalf of The Lancet Gastroenterology & Hepatology Commissioners.

The Lancet Gastroenterology & Hepatology, January 2019

Malaysia takes the lead on a public health approach to hepatitis C with new initiative to enhance diagnosis & treatment

New agreement between Clinical Research Malaysia & FIND on R&D for hepatitis C diagnostic tests continues an existing Malaysian partnership with DNDi for hepatitis C treatment

The Foundation for Innovative New Diagnostics (FIND) and Clinical Research Malaysia (CRM), both DNDi partners, recently signed a memorandum of understanding (MoU) to collaborate in the research and development of an innovative hepatitis C diagnostic testing strategy.

FIND and DNDi team up to support Malaysian MOH efforts to simplify and decentralize hepatitis C screening & treatment

Amsterdam/Geneva – 23 July 2018
Initiative in Malaysia to enhance country’s public health approach to hepatitis C
FIND and the DNDi will partner to generate evidence that will support policy change and scale up of hepatitis C diagnosis and treatment. This work, announced at the AIDS 2018 conference in Amsterdam and ahead of World Hepatitis Day 2018, is being conducted in collaboration with the Ministry of Health in Malaysia with a view to overcoming barriers to diagnosis and treatment.

Seminar on Evidence in Action

1 October 2018 
Subang Jaya, Malaysia
Jean-Michel Piedagnel, Head of DNDi South East Asia – presentation on affordable treatment for hepatitis C